on 14 Jun 2024
Last Applicant/ Owned by
JIANGSU ASCENTAGE PHARMA INC.
101 Room Of First Floor, Qb3 Building,Medical City Avenue,Taizhou225300 Jiangsu
CN
Serial Number
2183695 filed on 14th Mar 2022
Registration Number
TMA1238284 registered on 14th Jun 2024
Registration expiry Date
14th Mar 2032Correspondent Address
1100-150 York StreetToronto
ONTARIO
CA
M5H3S5
ASCENTAGE PHARMA
Vienna Information
26 . 2 . 7
Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses
26 . 2 . 12
Segments or sectors of circles or ellipses, semi-circles or semi-ellipses containing one or more geometrical figuresSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses contenant une ou plusieurs figures géométriques
26 . 2 . 18
Segments or sectors of circles or ellipses, semi-circles or semi-ellipses containing one or more lettersSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses contenant une ou plusieurs lettres
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
Trademark usage description
studies for combined compound functional mechanism on animals; cancer research for medical purposes; early evaluation for implementation of the new dr Read MoreClassification Information
Class [042]
Studies for combined compound functional mechanism on animals; cancer research for medical purposes; early evaluation for implementation of the new drugs; pharmaceutical research; scientific surveys for medical purposes; chemical analysis services; research and analysis of biochemistry; chemical research service; chemical analysis assessment service; chemical research and analysis; chemical synthesis assessment service; chemical analysis; chemical research; cosmetic research; structural and functional analysis of genomes; stem cell research services; biotechnological research; blood analysis service; genetic screening for scientific purposes; biological cloning services; research and development of antibodies; genetic testing for scientific research; bacteriological research and analysis; biomedical research; medical research; drug development; medical laboratory service; development of pharmaceutical preparations and pharmaceuticals; medical research service; biological research and analysis; bacteriological research; biological research; clinical trials; computer programming of medical aspects; drug evaluation; pharmaceutical research
Classification kind code
11
Mark Details
Serial Number
2183695
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 48 on 19th Jun 2023 | Agent Changed |
| Submitted for opposition 256 on 06th Mar 2023 | Notification of Possible Opposition Sent |
| Submitted for opposition 22 on 01st Mar 2023 | Search Recorded |
| Submitted for opposition 20 on 01st Mar 2023 | Examiner's First Report |
| Submitted for opposition 223 on 01st Mar 2023 | Total Provisional Refusal |
| Submitted for opposition 257 on 05th May 2022 | Designation Notification - Madrid Protocol |
| Submitted for opposition 1 on 05th May 2022 | Created |
| Submitted for opposition 31 on 05th May 2022 | Formalized |
| Submitted for opposition 30 on 14th Mar 2022 | Filed |
| Submitted for opposition 228 on 14th Mar 2022 | International Registration |